We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.65%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.75B
AUM Growth
+$182M
Cap. Flow
+$1.02M
Cap. Flow %
0.06%
Top 10 Hldgs %
16.22%
Holding
890
New
91
Increased
326
Reduced
388
Closed
74

Sector Composition

Rank Sector Weight
1 Healthcare 12.42%
2 Financials 10.3%
3 Technology 8.72%
4 Industrials 4.92%
5 Consumer Discretionary 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INBX
376
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.13M 0.06%
29,817
+2,086
+8% +$44.7K
MRO
377
DELISTED
Marathon Oil Corporation
MRO
$1.13M 0.06%
46,746
-6,796
-13% -$175K
CSGS
378
DELISTED
CSG Systems International
CSGS
$1.12M 0.06%
21,027
-1,831
-8% -$93.8K
NEM icon
379
Newmont
NEM
$124B
$1.12M 0.06%
27,031
-8,788
-25% -$339K
ABR icon
380
Arbor Realty Trust
ABR
$998M
$1.11M 0.06%
73,199
+41,710
+132% +$574K
CG icon
381
Carlyle Group
CG
$17.4B
$1.1M 0.06%
26,937
+11,194
+71% +$369K
FFIV icon
382
F5
FFIV
$23.4B
$1.1M 0.06%
6,123
-1,591
-21% -$260K
HWM icon
383
Howmet Aerospace
HWM
$112B
$1.09M 0.06%
20,209
+2,817
+16% +$139K
GXO icon
384
GXO Logistics
GXO
$5.37B
$1.09M 0.06%
17,747
+4,670
+36% +$262K
ATEN icon
385
A10 Networks
ATEN
$1.97B
$1.08M 0.06%
82,379
-22,126
-21% -$268K
RAPT
386
DELISTED
RAPT Therapeutics
RAPT
$1.08M 0.06%
5,452
+381
+8% +$47.2K
SLP icon
387
Simulations Plus
SLP
$370M
$1.08M 0.06%
24,051
+5,760
+31% +$228K
SQM icon
388
Sociedad Química y Minera de Chile
SQM
$20.6B
$1.07M 0.06%
17,696
-209
-1% -$11.1K
APD icon
389
Air Products & Chemicals
APD
$68.9B
$1.06M 0.06%
3,879
-425
-10% -$117K
INCY icon
390
Incyte
INCY
$24.5B
$1.06M 0.06%
16,890
+10,252
+154% +$580K
DGII icon
391
Digi International
DGII
$3.17B
$1.06M 0.06%
40,649
-849
-2% -$21.1K
OPK icon
392
Opko Health
OPK
$1.04B
$1.05M 0.06%
696,495
+28,975
+4% +$41.9K
NSSC icon
393
Napco Security Technologies
NSSC
$1.42B
$1.05M 0.06%
30,694
+5,779
+23% +$153K
ECL icon
394
Ecolab
ECL
$79.8B
$1.04M 0.06%
5,258
+1,871
+55% +$336K
ITCI
395
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.04M 0.06%
14,561
-203
-1% -$11.7K
LECO icon
396
Lincoln Electric
LECO
$15.5B
$1.04M 0.06%
4,794
+94
+2% +$18.1K
UFPT icon
397
UFP Technologies
UFPT
$2.49B
$1.04M 0.06%
6,019
-151
-2% -$24.5K
NFG icon
398
National Fuel Gas
NFG
$7.82B
$1.03M 0.06%
20,600
-4,991
-20% -$258K
CRSP icon
399
CRISPR Therapeutics
CRSP
$5.23B
$1.03M 0.06%
16,465
+1,150
+8% +$63.6K
WRB icon
400
W.R. Berkley
WRB
$26B
$1.03M 0.06%
21,839
-1,231
-5% -$56.1K

Similar funds

Hennion & Walsh Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Hennion & Walsh Asset Management held 890 positions worth $1.75B, up 12% from $1.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hennion & Walsh Asset Management's Q4 2023 filing shows 91 new, 326 increased, 388 reduced and 74 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 85,477 shares worth $6.01M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $6.66M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2023 buy was iShares Core MSCI EAFE ETF: 85,477 shares worth $6.01M.
  • Hennion & Walsh Asset Management added most to iShares National Muni Bond ETF in Q4 2023, an estimated $3.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2023 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $6.66M.
  • Hennion & Walsh Asset Management fully exited Immunovant in Q4 2023, selling an estimated $5.49M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 16% of its $1.75B portfolio in Q4 2023.
  • Hennion & Walsh Asset Management opened 91 new positions and closed 74 in Q4 2023.
  • Hennion & Walsh Asset Management's portfolio value rose 12% quarter-over-quarter to $1.75B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.